Sweden· SE-20230118000027

Apremilast Avansor 30 mg Filmdragerad tablett

A apremilast product containing apremilast, registered in Sweden by Avansor Pharma Oy. The same ATC class is registered in 18 of our 19 countries.

ATC L04AA32

Checked against Swedish Medical Products Agency (Sweden) on October 1, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about apremilastAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Apremilast is registered in 18 of 19 countries.

Countries holding a registration under ATC L04AA32 (apremilast), each read from that country’s own register.

This record: Sweden, from Swedish Medical Products Agency (Sweden)
10 of them publish a price we can compare per daily dose

Search apremilast products by name

Apremilast · ATC L04AA32

18 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of apremilast costs, country by country.

Normalised to the WHO defined daily dose (60 mg), the median price runs from $13.92 in Switzerland to $51.51 in Italy — a ×3.7 gap.

4 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Apremilast · price per daily dose (60 mg)

USD · FX 28 Sept 2026

IT Italy$51.51
CZ Czechia$51.22
FR France$22.59
CH Switzerland$13.92

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Swedish Medical Products Agency (Sweden)

Active substance: Apremilast
Manufacturer: Avansor Pharma Oy
Country: Sweden (SE)
ATC code: L04AA32
ATC class: Apremilast
Defined daily dose: 60 mg, O
Reimbursed: Not published by this register
Source register: Swedish Medical Products Agency (Sweden)
Last checked: October 1, 2026

Packs & prices · 1

se_varunummer
20230118000027

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

82 interactions on record for apremilast.

Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check apremilast against other medicines How interaction checks work

Apremilast · interactions on record

82 records

11 severe
69 moderate
2 minor

Most severe, free to view

RifampicinJ04AB02severe
MitotaneL01XX23severe
EnzalutamideL02BB04severe
ApalutamideL02BB05severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Apremilast in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All apremilast products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

Austria · Apremilast +pharma, Apremilast Devatis
Belgium · Apremilast Eg, Apremilast Hcs
Bulgaria · Тивлемак
Cyprus · Apremilast Ebewe, Apremilast Sandoz
Czechia · Apremilast +pharma, Apremilast Belupo
Germany · Apremilast, Apremilast 089pharm
Denmark · Apremilast Devatis, Apremilast Stada
Estonia · Apremilast Krka, Apremilast Stada
Spain · Apremilast, Apremilast Aurovitas Spain
Finland · Apremilast Avansor, Apremilast Bioglan
France · Apremilast Arrow, Apremilast Biogaran
United Kingdom (Northern Ireland) · Apremilast, Apremilast Amarox
Greece · Afimax, Apremilast Anabiosis
Croatia · Aperzyx, Apremilast Belupo
Hungary · Apremilast Kezdőcsomag Stada, Apremilast Krka
Ireland · Apremilast 30mg Tablets, Apremilast Aurobindo
Iceland · Apremilast Accord, Apremilast Aristo
Italy · Apremilast Day Zero, Apremilast Dr. Reddy’s
Liechtenstein · Apremilast Accord
Lithuania · Apremilast Krka, Apremilast Stada
Luxembourg · Apremilast Eg
Latvia · Apremilast Krka, Apremilast Stada
Malta · Apremilast, Apremilast Clonmel
Netherlands · Apremilast Amarox, Apremilast Devatis
Norway · Apremilast Accord, Apremilast Devatis
Poland · Apremilast Aristo, Apremilast Farmaprojects
Portugal · Apremilaste Humanis
Romania · Apremilast Stada
Slovenia · Apremilast Belupo, Apremilast Elpen
Slovakia · Apremilast Belupo, Apremilast Hcs

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/ac5bd108-4960-453a-a68c-e86dc3b435b5
GET /v1/drugs/ac5bd108-4960-453a-a68c-e86dc3b435b5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "lakemedelsverket",
  "doc_types": [
    "PL",
    "SmPC"
  ],
  "se_npl_id": "20230118000027",
  "product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20230118000027",
  "product_doc_link": "https://docetp.mpa.se/LMF/Apremilast%20Avansor%20film-coated%20tablet%20SmPC_09001bee83e01517.pdf"
}

API reference MCP server Plans

See everything about apremilast.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console